Back to ARK Investment Management LLC ARK Investment Management LLC

NTLANTLA

Showing 8 of 31 quarters

Position history for ARK Investment Management LLCARK Investment Management LLC's holdings in INTELLIA THERAPEUTICS INC

Yes. ARK Investment Management holds 16,875,684 shares of NTLA (Intellia Therapeutics), worth $285.5M, as of its Q2 2026 13F filing. It increased the position by 2,366,437 shares (+16.3%) from Q1 2026. ARK Investment Management has held NTLA in every 13F on record since Q4 2018, 31 quarterly filings. NTLA is 1.9% of ARK Investment Management's reported 13F portfolio.

Current Value

$285.5M

Current Shares

16.9M

Total Value Change

+$33.7M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16.9M
+16.3%
$285.5M1.9%$16.92
56
2026-Q1
Increased
14.5M
+2.1%
$186M1.4%$12.82
49
2025-Q4
Increased
14.2M
+19.2%
$127.7M0.8%$8.99
50
2025-Q3
Decreased
11.9M
-8.4%
$205.8M1.2%$17.27
0
2025-Q2
Increased
13M
+0.1%
$122.1M0.9%$9.38
42
2025-Q1
Increased
13M
+3.8%
$92.5M0.9%$7.11
44
2024-Q4
Increased
12.5M
+2.3%
$146.2M1.2%$11.66
49
2024-Q3
Increased
12.3M
+5.7%
$251.8M2.3%$20.55
56

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used